Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roach

Showing results (261-270 of 291) with videos related to

Pageof 30
Sort By:
Radiology|October 19, 2000
Treatment planning for clinically localized prostate cancer. American College of Radiology. ACR Appropriateness CriteriaM Roach, J C Blasko, C A Perez, et al.
Radiology|October 19, 2000
Definitive external beam irradiation in stage T1 and T2 carcinoma of the prostate. American College of Radiology. ACR Appropriateness CriteriaC A Perez, D C Beyer, J C Blasko, et al.
Radiology|October 19, 2000
Staging evaluation for patients with adenocarcinoma of the prostate. American College of Radiology. ACR Appropriateness CriteriaJ D Forman, W R Lee, M Roach, et al.
Radiology|October 19, 2000
Permanent source brachytherapy for prostate cancer. American College of Radiology. ACR Appropriateness CriteriaL Potters, C A Perez, D C Beyer, et al.
Radiology|October 19, 2000
Postradical prostatectomy irradiation in carcinoma of the prostate. American College of Radiology. ACR Appropriateness CriteriaC A Perez, D C Beyer, J C Blasko, et al.
International Journal of Cancer|December 18, 2001
Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA eraA B Jani, F Vaida, G Hanks, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2020
Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinomaEileen M O'Reilly, Diletta Barone, Devalingam Mahalingam, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|August 12, 2014
High interfacial activity of polymers "grafted through" functionalized iron oxide nanoparticle clustersLynn M Foster, Andrew J Worthen, Edward L Foster, et al.
Journal of the American Society of Nephrology : JASN|March 31, 2016
TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression of Fibrotic Kidney DiseaseIvan G Gomez, Allie M Roach, Naoki Nakagawa, et al.
International Journal of Cancer|June 19, 2001
Clinical staging of prostate cancer: reproducibility and clarification of issuesT Campbell, J Blasko, E D Crawford, et al.
Pageof 30

Showing results (261-270 of 291) with videos related to

Sort By:
Pageof 30
Radiology|October 19, 2000
Treatment planning for clinically localized prostate cancer. American College of Radiology. ACR Appropriateness CriteriaM Roach, J C Blasko, C A Perez, et al.
Radiology|October 19, 2000
Definitive external beam irradiation in stage T1 and T2 carcinoma of the prostate. American College of Radiology. ACR Appropriateness CriteriaC A Perez, D C Beyer, J C Blasko, et al.
Radiology|October 19, 2000
Staging evaluation for patients with adenocarcinoma of the prostate. American College of Radiology. ACR Appropriateness CriteriaJ D Forman, W R Lee, M Roach, et al.
Radiology|October 19, 2000
Permanent source brachytherapy for prostate cancer. American College of Radiology. ACR Appropriateness CriteriaL Potters, C A Perez, D C Beyer, et al.
Radiology|October 19, 2000
Postradical prostatectomy irradiation in carcinoma of the prostate. American College of Radiology. ACR Appropriateness CriteriaC A Perez, D C Beyer, J C Blasko, et al.
International Journal of Cancer|December 18, 2001
Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA eraA B Jani, F Vaida, G Hanks, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2020
Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinomaEileen M O'Reilly, Diletta Barone, Devalingam Mahalingam, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|August 12, 2014
High interfacial activity of polymers "grafted through" functionalized iron oxide nanoparticle clustersLynn M Foster, Andrew J Worthen, Edward L Foster, et al.
Journal of the American Society of Nephrology : JASN|March 31, 2016
TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression of Fibrotic Kidney DiseaseIvan G Gomez, Allie M Roach, Naoki Nakagawa, et al.
International Journal of Cancer|June 19, 2001
Clinical staging of prostate cancer: reproducibility and clarification of issuesT Campbell, J Blasko, E D Crawford, et al.
Pageof 30